Hematology
Conference Coverage
Early post-ACS bleeding may signal cancer
PARIS – Cancer risk is elevated with bleeding, whether or not DAPT is employed
From the Journals
Timing, volume of transfusion may not matter in children with severe anemia
The TRACT trial showed no significant differences in 28-day mortality or other clinical outcomes by transfusion timing or volume.
Conference Coverage
Sickle cell unit running 24/7 reduces readmissions, emergency visits
FORT LAUDERDALE, FLA. – An analysis of an around-the-clock sickle cell unit showed significant reductions in per-patient health care utilization...
Conference Coverage
No reduction in PE risk with vena cava filters after severe injury
MELBOURNE – “Given the cost and risks associated with a vena cava filter, our data suggest that there is no urgency to insert the filter in...
News from the FDA/CDC
CDC warns against misuse of opioid-prescribing guideline
Officials at the Centers for Disease Control and Prevention are advising against misapplication of the agency’s guideline on opioid prescribing....
Conference Coverage
Andexanet alfa effectively reverses factor Xa inhibition
HONOLULU – The drug establishes good or excellent hemostasis in 82% of patients with acute major bleeding associated...
From the Journals
ICYMI: Andexanet alfa reduces anti–factor Xa activity from apixaban, rivaroxaban
Reductions were similar for those receiving apixaban and rivaroxaban.
News
FDA aims to boost safety of platelets for transfusion
The agency is seeking input on ways to decrease the risk of bacterial contamination in platelets stored for 5 and 7 days after collection.
From the Journals
Improved treatments emerge for hemophilia patients with high-titer inhibitors
Use of traditional bypassing agents is expected to decrease over time as improved therapeutics are developed.
Conference Coverage
Need blood STAT? Call for a drone
BOSTON – Autonomous unmanned aerial vehicles bring blood to remote hospitals in Africa, but a U.S.-based system will need to overcome significant...
News
FDA approves DNA-based blood type test
This is the first molecular-based test for red blood cell types to report genotypes in its results.